Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Ovarian Neoplasms × pegilodecakin × Clear all

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

pegilodecakin 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03554434 2020-03-02

An Expanded Access Program for AM0010 (Pegilodecakin)

Eli Lilly and Company

No longer available

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡